Trial Profile
Phase I/II trial of recombinant human thymosin beta-4 in acute myocardial infarction
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 18 Mar 2016
Price :
$35
*
At a glance
- Drugs Timbetasin (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- Sponsors Beijing Northland Biotech
- 18 Mar 2016 New trial record